Literature DB >> 26399579

Tracking vaginal, anal and oral infection in a mouse papillomavirus infection model.

Jiafen Hu1,2, Lynn R Budgeon1,2, Nancy M Cladel1,2, Karla Balogh1,2, Roland Myers3, Timothy K Cooper4, Neil D Christensen5,1,2.   

Abstract

Noninvasive and practical techniques to longitudinally track viral infection are sought after in clinical practice. We report a proof-of-principle study to monitor the viral DNA copy number using a newly established mouse papillomavirus (MmuPV1) mucosal infection model. We hypothesized that viral presence could be identified and quantified by collecting lavage samples from cervicovaginal, anal and oral sites. Nude mice infected at these sites with infectious MmuPV1 were tracked for up to 23 weeks starting at 6 weeks post-infection. Viral DNA copy number was determined by SYBR Green Q-PCR analysis. In addition, we tracked viral DNA load through three complete oestrous cycles to pinpoint whether there was a correlation between the DNA load and the four stages of the oestrous cycle. Our results showed that high viral DNA copy number was reproducibly detected from both anal and cervicovaginal lavage samples. The infection and disease progression were further confirmed by histology, cytology, in situ hybridization, immunohistochemistry and transmission electron microscopy. Interestingly, the viral copy number fluctuated over the oestrous cycle, with the highest level at the oestrus stage, implying that multiple sampling might be necessary to provide a reliable diagnosis. Virus DNA was detected in oral lavage samples at a later time after infection. Lower viral DNA load was found in oral samples when compared with those in anal and vaginal tracts. To our knowledge, our study is the first in vivo study to sequentially monitor papillomavirus infection from mucosal anal, oral and vaginal tracts in a preclinical model.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26399579      PMCID: PMC4804763          DOI: 10.1099/jgv.0.000295

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  67 in total

1.  Vaginal lavage attenuates cocaine-stimulated activity and establishes place preference in rats.

Authors:  Q David Walker; Christina J Nelson; Daegan Smith; Cynthia M Kuhn
Journal:  Pharmacol Biochem Behav       Date:  2002-11       Impact factor: 3.533

Review 2.  An integrative review of guidelines for anal cancer screening in HIV-infected persons.

Authors:  Jessica S Wells; Marcia M Holstad; Tami Thomas; Deborah Watkins Bruner
Journal:  AIDS Patient Care STDS       Date:  2014-06-17       Impact factor: 5.078

3.  Comparison of subgingival bacterial sampling with oral lavage for detection and quantification of periodontal pathogens by real-time polymerase chain reaction.

Authors:  Khalil Boutaga; Paul H M Savelkoul; Edwin G Winkel; Arie J van Winkelhoff
Journal:  J Periodontol       Date:  2007-01       Impact factor: 6.993

4.  Effect of the estrous cycle on susceptibility of female mice to intravaginal inoculation of herpes simplex virus type 2 (HSV-2).

Authors:  A G Teepe; L B Allen; R J Wordinger; E F Harris
Journal:  Antiviral Res       Date:  1990 Oct-Nov       Impact factor: 5.970

Review 5.  Prevalence of anal human papillomavirus infection and anal HPV-related disorders in women: a systematic review.

Authors:  Elizabeth A Stier; Meagan C Sebring; Audrey E Mendez; Fatimata S Ba; Debra D Trimble; Elizabeth Y Chiao
Journal:  Am J Obstet Gynecol       Date:  2015-03-19       Impact factor: 8.661

Review 6.  Viral determinants of cellular tropism.

Authors:  W A O'Brien
Journal:  Pathobiology       Date:  1992       Impact factor: 4.342

7.  Prevalence and risk factors for oral human papillomavirus infection in 129 women screened for cervical HPV infection.

Authors:  Moritz F Meyer; Christian U Huebbers; Oliver G Siefer; Julia Vent; Iris Engbert; Guy D Eslick; Markus Valter; Jens Peter Klussmann; Simon F Preuss
Journal:  Oral Oncol       Date:  2013-10-26       Impact factor: 5.337

Review 8.  Anorectal human papillomavirus: current concepts.

Authors:  Roland Assi; Vikram Reddy; Hulda Einarsdottir; Walter E Longo
Journal:  Yale J Biol Med       Date:  2014-12-12

9.  Immune status, strain background, and anatomic site of inoculation affect mouse papillomavirus (MmuPV1) induction of exophytic papillomas or endophytic trichoblastomas.

Authors:  John P Sundberg; Timothy M Stearns; Joongho Joh; Mary Proctor; Arvind Ingle; Kathleen A Silva; Soheil S Dadras; A Bennett Jenson; Shin-je Ghim
Journal:  PLoS One       Date:  2014-12-04       Impact factor: 3.240

10.  Vaginal self-sampling is a cost-effective way to increase participation in a cervical cancer screening programme: a randomised trial.

Authors:  K Haguenoer; S Sengchanh; C Gaudy-Graffin; J Boyard; R Fontenay; H Marret; A Goudeau; N Pigneaux de Laroche; E Rusch; B Giraudeau
Journal:  Br J Cancer       Date:  2014-09-23       Impact factor: 7.640

View more
  25 in total

Review 1.  More than just oncogenes: mechanisms of tumorigenesis by human viruses.

Authors:  Marta M Gaglia; Karl Munger
Journal:  Curr Opin Virol       Date:  2018-09-27       Impact factor: 7.090

2.  Mouse papillomavirus infections spread to cutaneous sites with progression to malignancy.

Authors:  Nancy M Cladel; Lynn R Budgeon; Timothy K Cooper; Karla K Balogh; Neil D Christensen; Roland Myers; Vladimir Majerciak; Deanna Gotte; Zhi-Ming Zheng; Jiafen Hu
Journal:  J Gen Virol       Date:  2017-10       Impact factor: 3.891

3.  Passive Immunization with a Single Monoclonal Neutralizing Antibody Protects against Cutaneous and Mucosal Mouse Papillomavirus Infections.

Authors:  Sarah A Brendle; Jingwei Li; Nancy M Cladel; Karla K Balogh; Jennifer Booth; Debra A Shearer; Vonn Walter; Song Lu; Neil D Christensen; Danielle Covington; Jake DeBroff; Janice Milici; Yusheng Zhu; Raphael Viscidi; Jiafen Hu
Journal:  J Virol       Date:  2022-08-03       Impact factor: 6.549

4.  Insights into the Role of Innate Immunity in Cervicovaginal Papillomavirus Infection from Studies Using Gene-Deficient Mice.

Authors:  Carolina Scagnolari; Fabiana Cannella; Alessandra Pierangeli; Rebecca Mellinger Pilgrim; Guido Antonelli; Dayana Rowley; Margaret Wong; Simon Best; Deyin Xing; Richard B S Roden; Raphael Viscidi
Journal:  J Virol       Date:  2020-06-01       Impact factor: 5.103

Review 5.  Recent advances in preclinical model systems for papillomaviruses.

Authors:  Neil D Christensen; Lynn R Budgeon; Nancy M Cladel; Jiafen Hu
Journal:  Virus Res       Date:  2016-12-09       Impact factor: 3.303

6.  The environmental pollutant and tobacco smoke constituent dibenzo[def,p]chrysene is a co-factor for malignant progression of mouse oral papillomavirus infections.

Authors:  Neil D Christensen; Kun-Ming Chen; Jiafen Hu; Douglas B Stairs; Yuan-Wan Sun; Cesar Aliaga; Karla K Balogh; Hannah Atkins; Debra Shearer; Jingwei Li; Sarah A Brendle; Krishne Gowda; Shantu Amin; Vonn Walter; Raphael Viscidi; Karam El-Bayoumy
Journal:  Chem Biol Interact       Date:  2020-11-10       Impact factor: 5.168

7.  Mouse papillomavirus infection persists in mucosal tissues of an immunocompetent mouse strain and progresses to cancer.

Authors:  Nancy M Cladel; Lynn R Budgeon; Karla K Balogh; Timothy K Cooper; Sarah A Brendle; Neil D Christensen; Todd D Schell; Jiafen Hu
Journal:  Sci Rep       Date:  2017-12-05       Impact factor: 4.379

Review 8.  Mus musculus Papillomavirus 1: a New Frontier in Animal Models of Papillomavirus Pathogenesis.

Authors:  Megan E Spurgeon; Paul F Lambert
Journal:  J Virol       Date:  2020-04-16       Impact factor: 5.103

9.  Humans with inherited T cell CD28 deficiency are susceptible to skin papillomaviruses but are otherwise healthy.

Authors:  Vivien Béziat; Franck Rapaport; Jiafen Hu; Matthias Titeux; Mathilde Bonnet des Claustres; Mathieu Bourgey; Heather Griffin; Élise Bandet; Cindy S Ma; Roya Sherkat; Hassan Rokni-Zadeh; David M Louis; Majid Changi-Ashtiani; Ottavia M Delmonte; Toshiaki Fukushima; Tanwir Habib; Andrea Guennoun; Taushif Khan; Noemi Bender; Mahbuba Rahman; Frédégonde About; Rui Yang; Geetha Rao; Claire Rouzaud; Jingwei Li; Debra Shearer; Karla Balogh; Fatima Al Ali; Manar Ata; Soroosh Dabiri; Mana Momenilandi; Justine Nammour; Marie-Alexandra Alyanakian; Marianne Leruez-Ville; David Guenat; Marie Materna; Léa Marcot; Natasha Vladikine; Christine Soret; Hassan Vahidnezhad; Leila Youssefian; Amir Hossein Saeidian; Jouni Uitto; Émilie Catherinot; Shadi Sadat Navabi; Mohammed Zarhrate; David T Woodley; Mohamed Jeljeli; Thomas Abraham; Serkan Belkaya; Lazaro Lorenzo; Jérémie Rosain; Mousa Bayat; Fanny Lanternier; Olivier Lortholary; Faramarz Zakavi; Philippe Gros; Gérard Orth; Laurent Abel; Jean-Luc Prétet; Sylvie Fraitag; Emmanuelle Jouanguy; Mark M Davis; Stuart G Tangye; Luigi D Notarangelo; Nico Marr; Tim Waterboer; David Langlais; John Doorbar; Alain Hovnanian; Neil Christensen; Xavier Bossuyt; Mohammad Shahrooei; Jean-Laurent Casanova
Journal:  Cell       Date:  2021-07-01       Impact factor: 66.850

10.  Spontaneous and Vaccine-Induced Clearance of Mus Musculus Papillomavirus 1 Infection.

Authors:  Rosie T Jiang; Joshua W Wang; Shiwen Peng; Tsui-Chin Huang; Chenguang Wang; Fabiana Cannella; Yung-Nien Chang; Raphael P Viscidi; Simon R A Best; Chien-Fu Hung; Richard B S Roden
Journal:  J Virol       Date:  2017-07-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.